Why tocilizumab could be an effective treatment for severe COVID-19? | Journal of Translational Medicine | Full Text
Clinical experience of IL-6 blockade in rheumatic diseases—Implications on IL-6 biology and disease pathogenesis - ScienceDirect
A review of sarilumab for the treatment of rheumatoid arthritis | Immunotherapy
Interleukin-6 inhibition in the management of non-infectious uveitis and beyond | Journal of Ophthalmic Inflammation and Infection | Full Text
Immunomodulation as a potent COVID-19 pharmacotherapy | JIR
![The efficacy of IL-6 inhibitor Tocilizumab in reducing severe COVID-19 mortality: a systematic review [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2020/10322/1/fig-3-full.png "The efficacy of IL-6 inhibitor Tocilizumab in reducing severe COVID-19 mortality: a systematic review [PeerJ]")
The efficacy of IL-6 inhibitor Tocilizumab in reducing severe COVID-19 mortality: a systematic review [PeerJ]
Frontiers | Current Evidence of Interleukin-6 Signaling Inhibitors in Patients With COVID-19: A Systematic Review and Meta-Analysis | Pharmacology
Risk of reactivation of hepatitis B virus (HBV) and tuberculosis (TB) and complications of hepatitis C virus (HCV) following Tocilizumab therapy: A systematic review to inform risk assessment in the COVID era
Why tocilizumab could be an effective treatment for severe COVID-19? | Journal of Translational Medicine | Full Text
Role of IL-6 inhibitor in treatment of COVID-19-related cytokine release syndrome
Frontiers | Tocilizumab: The Key to Stop Coronavirus Disease 2019 (COVID-19)-Induced Cytokine Release Syndrome (CRS)? | Medicine
Subcutaneous formulation of tocilizumab for treatment of rheumatoid arthritis | Therapeutic Delivery
Outlook of IL-6 signaling blockade for COVID-19 pneumonia | Inflammation and Regeneration | Full Text
Tocilizumab in the treatment of adult rheumatoid arthritis | Immunotherapy
Mechanism of action of tocilizumab in RA (bathtub theory). Notes: The... | Download Scientific Diagram
Low immunogenicity of tocilizumab in patients with rheumatoid arthritis | Annals of the Rheumatic Diseases
Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia | SpringerLink
Tocilizumab-Atlizumab Overview - Creative Biolabs
Actemra | Uses, Safety Info & Comparison to Other RA Drugs
Tocilizumab for treatment patients with COVID-19: Recommended medication for novel disease - ScienceDirect
Anti‐interleukin‐6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases - Tanaka - 2011 - FEBS Letters - Wiley Online Library
